- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2055-7124
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Nonviral delivery systems for antisense oligonucleotide therapeutics ; volume:26 ; number:1 ; day:30 ; month:9 ; year:2022 ; pages:1-23 ; date:12.2022
Biomaterials Research ; 26, Heft 1 (30.9.2022), 1-23, 12.2022
- Creator
-
Huang, Si
Hao, Xin-Yan
Li, Yong-Jiang
Wu, Jun‑Yong
Xiang, Da-Xiong
Luo, Shilin
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40824-022-00292-4
- URN
-
urn:nbn:de:101:1-2022121809062485671859
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Huang, Si
- Hao, Xin-Yan
- Li, Yong-Jiang
- Wu, Jun‑Yong
- Xiang, Da-Xiong
- Luo, Shilin
- SpringerLink (Online service)
Other Objects (12)
Delivery of oligonucleotide‐based therapeutics: challenges and opportunities
Triazine-cored polymeric vectors for antisense oligonucleotide delivery in vitro and in vivo
Antisense oligonucleotide therapeutic approach for Timothy syndrome
Systemic Brain Delivery of Oligonucleotide Therapeutics Enhanced by Protein Corona‐Assisted DNA Cubes
Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
Oligonucleotide therapeutics in sports? An antidoping perspective
Pharmacological studies of antisense oligonucleotide microRNA inhibitors
Profiled support vector machines for antisense oligonucleotide efficacy prediction
Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
Multi-targeted Antisense Oligonucleotide Delivery by a Framework Nucleic Acid for Inhibiting Biofilm Formation and Virulence
Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
Emerging non-viral vectors for gene delivery
Delivery of oligonucleotide‐based therapeutics: challenges and opportunities
Triazine-cored polymeric vectors for antisense oligonucleotide delivery in vitro and in vivo
Antisense oligonucleotide therapeutic approach for Timothy syndrome
Systemic Brain Delivery of Oligonucleotide Therapeutics Enhanced by Protein Corona‐Assisted DNA Cubes
Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
Oligonucleotide therapeutics in sports? An antidoping perspective
Pharmacological studies of antisense oligonucleotide microRNA inhibitors
Profiled support vector machines for antisense oligonucleotide efficacy prediction
Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
Multi-targeted Antisense Oligonucleotide Delivery by a Framework Nucleic Acid for Inhibiting Biofilm Formation and Virulence
Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
Emerging non-viral vectors for gene delivery
Delivery of oligonucleotide‐based therapeutics: challenges and opportunities
Triazine-cored polymeric vectors for antisense oligonucleotide delivery in vitro and in vivo
Antisense oligonucleotide therapeutic approach for Timothy syndrome
Systemic Brain Delivery of Oligonucleotide Therapeutics Enhanced by Protein Corona‐Assisted DNA Cubes
Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
Oligonucleotide therapeutics in sports? An antidoping perspective
Pharmacological studies of antisense oligonucleotide microRNA inhibitors
Profiled support vector machines for antisense oligonucleotide efficacy prediction
Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
Multi-targeted Antisense Oligonucleotide Delivery by a Framework Nucleic Acid for Inhibiting Biofilm Formation and Virulence
Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle